TMO
Thermo Fisher Scientific Inc.
Stock
$675.05−4.56 (−0.67%)Close Sep 30, 2026
| Net income (TTM) | YoY | 5-year CAGR | 10-year CAGR |
|---|---|---|---|
| $7.0B | +5.8% | 1.0% | 13.0% |
| Net income (TTM) | $7.0B |
|---|---|
| YoY | +5.8% |
| 5-year CAGR | 1.0% |
| 10-year CAGR | 13.0% |
Net income
| Period | Net income | YoY |
|---|---|---|
| 2025 | $6.7B | +5.8% |
| 2024 | $6.3B | +5.7% |
| 2023 | $6.0B | −13.7% |
| 2022 | $7.0B | −10.0% |
| 2021 | $7.7B | +21.2% |
| 2020 | $6.4B | +72.5% |
| 2019 | $3.7B | +25.8% |
| 2018 | $2.9B | +32.0% |
| 2017 | $2.2B | +10.0% |
| 2016 | $2.0B | +2.4% |
| 2015 | $2.0B | +4.3% |
| 2014 | $1.9B | +48.8% |
| 2013 | $1.3B | +8.1% |
| 2012 | $1.2B | −11.4% |
| 2011 | $1.3B | +28.4% |
| 2010 | $1.0B | +21.8% |
| 2009 | $850M | −13.3% |
| 2008 | $981M | +31.1% |
| 2007 | $748M | — |